AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇹🇳

OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE in Tunisia

8 products registered with DPM — 0 active, 8 expired

Brand / ProductReg. No.HolderStatusExpires
OLMECARD PLUS
Comprimé pelliculé / 40mg/12.5mg
9403123THERAexpired30 Mar 2021
OLMECARD PLUS
Comprimé pelliculé / 20mg/25mg
9403122THERAexpired30 Mar 2021
OLMECARD PLUS
Comprimé pelliculé / 20mg/12.5mg
9403121THERAexpired30 Mar 2021
OLMECARD PLUS
Comprimé pelliculé / 40mg/25mg
9403124THERAexpired30 Mar 2021
COOLMETEC
Comprimé pelliculé / 40 mg/12.5 mg
12803043DAIICHI SANKYO FRANCE S.A.Sexpired15 Jan 2014
COOLMETEC
Comprimé pelliculé / 40 mg/25mg
12803044DAIICHI SANKYO FRANCE S.A.Sexpired8 Jan 2014
COOLMETEC
Comprimé pelliculé / 20 mg/12.5 mg
12803041DAIICHI SANKYO FRANCE S.A.Sexpired14 Apr 2007
COOLMETEC
Comprimé pelliculé / 20 mg/25mg
12803042DAIICHI SANKYO FRANCE S.A.Sexpired14 Apr 2007

OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE — DPM Registration Details

DPM (Tunisia) has 8 registered products containing OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.

Track OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Olmesartan Medoxomil Hydrochlorothiazide — Tunisia (DPM) | AfricaRegulatory